Beom Joon [BJ] Kim

ICYMI: Check out #Stroke #EditorPick, "Timing of Initiation and Efficacy of Dual Antiplatelet Therapy in Minor Stroke or High-Risk TIA." @KimBJstroke ahajournals.org/doi/full/10.11…

Great to be at #ISC2026. The fireside chat sessions translate surprisingly well to commute listening. This year's Science on Demand platform also offers MP3 downloads — a small but very practical upgrade. 🎧 #StrokeTwitter

I thank Prof. Noguera for citing my article in the ORIENTAL-MeVO trial introduction at #ISC2026. Emerging evidence suggests EVT benefits #stroke patients with DMVO, particularly those with high NIHSS scores. 🔗 ahajournals.org/doi/10.1161/JA…

🚨Suboptimal #TICI2c3 reperfusion rates may have been a reason for neutral #MeVO #EVT trial results 🤔*Close association reperfusion grade ➡️90-day mRS* ...check out this paper by Will Diprose and the #EscapeMeVO team👀 jnis.bmj.com/content/early/…

ORIENT-MeVO showed the benefit of EVT for MeVO, although ACA and PCA occlusions accounted for more than 1/3 of the randomized subjects.

As an international participant at #ISC26, I deeply appreciate AHA/ASA's effort to provide AI-supported real-time translation. This is an important step toward broader global engagement.

Bridging TNK before EVT may not be an option… TNK-PLUS trial at #ISC26

Additional TNK over EVT for BAO after 4.5 hours: no benefit - reaffirm TIMELESS?

TNK is beneficial for non~LVO after 4.5 hours. #isc26 OPTION trial

Finally, we have a new weapon. OCEANIC trial showed benefit and safety of Asundexian #ISC26

For years, I've been coming to ISC to sit down and learn. This year, as a Program Committee member, I had the chance to give back, even if in a small way. Seeing the results of that work here and there is rewarding. With the sessions from #ISC26, I hope to do more in Houston.

#ISC26 marks my 20th year since first attending as a neurology resident. The annual February ritual, flying across the Pacific, still takes its toll on my body clock. But the ISC has grown bigger, better, richer in science. Twenty years in, and I'm still learning as much as ever.

What I enjoy about #ISC26 : casual hallway catch-ups with colleagues from around the world, and the deeper conversations over coffee and Po-Boy. Love hearing results that could reshape clinical practice, and glimpsing the brilliant minds pushing the boundaries of what we know.

FVIIa decreased ICH volume growth but no gain in functional outcome. #isc26 Better trends in cases with earlier administration and with spot signs

CHOICE-2 proved the benefit of adjuvant thrombolysis after EVT #isc26

At ISC 2026 in New Orleans this week. Always great to be part of the conversation on advancing stroke care. Drop me a line if you're around! #ISC26

Recently, we’ve seen an influx of template-based letters likely generated by AI. These contribute nothing to the literature and only serve to inflate CVs. As editors, we must differentiate between genuine discussion and automated noise. A timely editorial: journals.stfm.org/primer/2025/ed…

📢Get ready for #WSC2025 in Barcelona 🇪🇸, Oct 22–24! Dive into cutting-edge Stroke #Imaging insights from global experts🌐at @WorldStrokeOrg! @ShadiYaghi2 @KimBJstroke @ChaturvediNeuro @MicheleRomoli @GuidoFalconeMD 📖Prog: worldstrokecongress.org/scientific-pro… 🖊️Reg: worldstrokecongress.org/registration

Idiopathic Intracranial Hypertension | New England Journal of Medicine nejm.org/doi/full/10.10…